"A Kenézy Gyula Egyetemi Kórház 2021 januárban megszűnt és a Debreceni Egyetem Klinikai Központ ( DEKK) részévé vált, Kenézy Gyula Campus néven. A DEKK így hazánk egyik legnagyobb egészségügyi szolgáltatójaként két Campuson (Nagyerdei és Kenézy Gyula Campusok) széleskörű, a progresszivitás legmagasabb szintjét képviselő diagnosztikai, betegellátó és ehhez kapcsolódó oktató és kutató tevékenységet folytat."

During the past decade, Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz" #1 sponsor was "Amgen" with 2 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 1 trials sponsored and "SK Life Science, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz" are "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Alzheimer´s Disease" (1 trials), "Atopic Dermatitis" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Migraine Headache" (1 trials). Many other conditions were trialed in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz" in a lesser frequency.

Most popular intervention types in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AVP-786" (2 trials), "Erenumab 140mg" (1 trials), "Erenumab 70 mg" (1 trials) and "Gan & Lee Insulin Lispro Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".